LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Biomedical Advanced Research & Development Authority (BARDA) Accelerator Network Collaborative Virtual Series
Event | 07. 01. 2022
Art Pappas will be participating in BARDA's Accelerator Network Collaborative Virtual Series panel discussion titled "Scale your Company via Strategic Partnerships & Venture Financing" on July 1st from 12:00-1:30 PM EDT.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.